To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
Clinical trial NCT05476887 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05476887
- Sponsor
- Kira Pharmacenticals (US), LLC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-25
- Primary completion
- 2024-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.